Buntanetap/Posiphen

Drug identity checked against registry records

Also recorded as Posiphen Tartrate

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADNCT05686044ANVSPhase 2, Phase 3Completed2024-02-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.